VG-204

N/A

Report date: 2022/06/24 17:26:41

Base Information

Drug NameVG-204
Drug Alias NameVG-204
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterleukin-12 stimulantsInterleukin-15 stimulantsInterleukin-15 receptor subunit alpha stimulants
TargetsInterleukin-15 receptor subunit alphaInterleukin-15Interleukin-12 receptor +[4] 
Therapy Area/IndicationsSolid tumoursGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViroGin Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViroGin Biotech Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A